These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16803511)

  • 101. Expression of cancer stem markers could be influenced by silencing of p16 gene in HeLa cervical carcinoma cells.
    Wu H; Zhang J; Shi H
    Eur J Gynaecol Oncol; 2016; 37(2):221-5. PubMed ID: 27172749
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer.
    Jung S; Jeong D; Kim J; Yi L; Koo K; Lee J; Kim CJ; Kim CH; An S; Yang Y; Lim JS; Kim KI; Lee MS
    Int J Oncol; 2011 Mar; 38(3):859-69. PubMed ID: 21240459
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Methylation of p16INK4A in primary gynecologic malignancy.
    Wong YF; Chung TK; Cheung TH; Nobori T; Yu AL; Yu J; Batova A; Lai KW; Chang AM
    Cancer Lett; 1999 Mar; 136(2):231-5. PubMed ID: 10355753
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.
    Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa.
    Arisawa T; Tahara T; Tsutsumi M; Shibata T
    BMC Med Genet; 2012 Jul; 13():59. PubMed ID: 22827846
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia.
    Li RN; Li CY; Lee CH; Peng CY; Wu MT
    Oncol Lett; 2017 Jun; 13(6):4397-4401. PubMed ID: 28599442
    [TBL] [Abstract][Full Text] [Related]  

  • 107. ESR1 promoter methylation in squamous cell cervical cancer.
    Kirn V; Zaharieva I; Heublein S; Thangarajah F; Friese K; Mayr D; Jeschke U
    Anticancer Res; 2014 Feb; 34(2):723-7. PubMed ID: 24511005
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.
    Hoque MO; Begum S; Brait M; Jeronimo C; Zahurak M; Ostrow KL; Rosenbaum E; Trock B; Westra WH; Schoenberg M; Goodman SN; Sidransky D
    J Urol; 2008 Feb; 179(2):743-7. PubMed ID: 18082200
    [TBL] [Abstract][Full Text] [Related]  

  • 109. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
    Li C; Ke J; Liu J; Su J
    J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Death-associated protein kinase is essential for the survival of various types of uterine cancer cells.
    Tanaka T; Bai T; Yukawa K
    Int J Oncol; 2010 Oct; 37(4):1017-22. PubMed ID: 20811724
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder].
    Friedrich MG; Toma MI; Chun JK; Steuber T; Budäus L; Isbarn H; Huland H
    Urologe A; 2007 Jul; 46(7):761-8. PubMed ID: 17522834
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
    Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
    Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
    [TBL] [Abstract][Full Text] [Related]  

  • 114. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
    Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
    PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.
    Abudukadeer A; Bakry R; Goebel G; Mutz-Dehbalaie I; Widschwendter A; Bonn GK; Fiegl H
    Int J Mol Sci; 2012; 13(7):8353-8363. PubMed ID: 22942707
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis.
    Xiong J; Li Y; Huang K; Lu M; Shi H; Ma L; Luo A; Yang S; Lu Z; Zhang J; Yang L; Wang S
    PLoS One; 2014; 9(9):e107272. PubMed ID: 25268905
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer.
    Jabłonowski Z; Reszka E; Gromadzińska J; Wąsowicz W; Sosnowski M
    Arch Med Sci; 2011 Jun; 7(3):512-6. PubMed ID: 22295037
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Methylation pattern of
    Holubeková V; Mendelová A; Grendár M; Meršaková S; Kapustová I; Jašek K; Vaňochová A; Danko J; Lasabová Z
    Oncol Lett; 2016 Oct; 12(4):2613-2621. PubMed ID: 27703524
    [TBL] [Abstract][Full Text] [Related]  

  • 119. DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis.
    Agodi A; Barchitta M; Quattrocchi A; Maugeri A; Vinciguerra M
    PLoS One; 2015; 10(8):e0135078. PubMed ID: 26267895
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients.
    Sasaki H; Hikosaka Y; Kawano O; Moriyama S; Yano M; Fujii Y
    Oncol Lett; 2010 Mar; 1(2):283-287. PubMed ID: 22966295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.